¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acquired reactive perforating dermatosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® dermatosis ÇÑ±Û ÇǺκ´
¼³¸í   
  ÇǺο¡ »ý±â´Â ¸ðµç º´ÀÇ ÃÑĪ. ÇǺδ ½ÅüÀǠǥ¸éÀ» µ¤°í ÀÖÀ¸¹Ç·Î ¿Ü°è·ÎºÎÅÍ ÀÚ±ØÀ̳ª ¿©·¯ º´¿øÃ¼¿¡ Á÷Á¢ Á¢Ã˵ɠ±âȸ°¡ ¸¹°í, Ã¼³»·ÎºÎÅÍ ¿µÇâÀ» °­ÇϰԠ¹Þ´Â´Ù. ´õ¿íÀÌ ÇǺÎÀÇ ±Ù¼ÒÇÑ º¯È­µµ ´«À¸·Î º¸°í ¼ÕÀ¸·Î ¸¸Áú ¼ö ÀÖÀ¸¸ç, º´º¯ºÎÀÇ ÀϺθ¦ Ã¤ÃëÇÏ¿© º´¸®Á¶Á÷ÇÐÀûÀ¸·Î °Ë»çÇϰųª, ¹Ì»ý¹°ÀÇ °Ë»ö µîÀÇ °Ë»ç¸¦ Çϱ⠽±°í, °³°³ÀÇ Áúº´ÀÇ Áø´ÜÀ» ¸íÈ®ÇϰԠÇϴ °ÍÀÌ ¿ëÀÌÇϹǷÎ, ±× Á¾·ù´Â ´Ù¸¥ Àå±âÀÇ ±×°Í¿¡ ºñÇÏ¿© »ó´çÇÑ ¼ö¿¡ À̸£¸ç, º´¸íµµ º¹Àâ ´Ù¾çÇÏ´Ù. Å©°Ô ³ª´©¸é ´ÙÀ½°ú °°´Ù. º¯È­°¡ ÇǺο¡ ÇÑÁ¤µÈ °Í¿¡´Â ¹ÝÁ¡-Á¡ µîÀÌ ÀÖ°í, Àü½Å¿¡ ¹ÌÄ¡´Â °Í¿¡´Â ¾Æ±³Áúº´, ºñŸ¹Î°áÇ̼º ÇǺκ´, ³»ºÐºñÀå¾Ö¼º ÇǺκ´ µîÀÌ Æ÷ÇԵȴÙ. ´Ù¸¸ ÇǺθ¦ Á¦¿ÜÇÑ ºÎºÐÀ» ÇǺο¡ ´ëÇÏ¿© Àü½ÅÀ¸·Î °£ÁÖÇϴ °æ¿ì, º¯È­°¡ ÇǺο¡¸¸ ÇÑÁ¤µÇ´Â °ÍÀº Àû°í, ´ëºÎºÎºÐÀÇ ÇǺκ´Àº Ç÷¾×ÀÇ º¯È­³ª °£±â´ÉÀå¾Ö µîÀÇ Àü½ÅÇö»óÀ» ¼ö¹ÝÇÑ´Ù. ¼¼±Õ-¹ÙÀÌ·¯½º µîÀÇ º´¿øÃ¼°¡ ¿øÀÎÀΠÁúº´¿¡´Â ¼öµÎ-³ó°¡Áø-¸Åµ¶ µîÀÌ ÀÖ°í, °¢°¢ Àü¿°ÇÏÁö¸¸, ½ÀÁø-¹ÝÁ¡-Á¾¾ç ¶Ç´Â ¾Æ±³Áúº´ µîÀº Àü¿°ÇÏÁö ¾Ê´Â´Ù. ÇǺκ´ÀÇ ³»ÀÎÀ¸·Î´Â À§ÀåÀå¾Ö-°£º´-ÄáÆÏº´-¹°Áú´ë»çÀå¾Ö-Ç÷¾×Áúȯ-³»ÀåÁ¾¾ç-³»ºÐºñÀå¾Ö µîÀ» µé ¼ö ÀÖ´Ù.
¿µ¹® acquired immunodeficiency syndrome ÇÑ±Û ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
¼³¸í   
  Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV)¿¡ ÀÇÇÏ¿© ¸é¿ª ¼¼Æ÷°¡ ÆÄ±«µÊÀ¸·Î½á ÀÎüÀÇ ¸é¿ª´É·ÂÀÌ ±Øµµ·Î ÀúÇϵǾ´¿øÃ¼¿¡ ´ëÇÏ¿© ¹«¹æºñ »óÅ¿¡ À̸£´Â º´. ¿¡ÀÌÁî ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â¸ç, 1981³â ¹Ì±¹¿¡¼­ Ã³À½ º¸°íµÇ¾ú´Ù. ÃÖÃÊ °¨¿°À¸·ÎºÎÅÍ Áõ»óÀÌ ³ªÅ¸³ª±â±îÁö´Â Æò±Õ 10³â Á¤µµ °É¸®¸ç »ç¸Á·üÀÌ ´ë´ÜÈ÷ ³ô´Ù. ¼ºÀû Á¢ÃË, ¿À¿° ÁÖ»ç±â »ç¿ë, ¿À¿° Ç÷¾× ¹× Ç÷¾× Á¦Á¦ »ç¿ë, ¿¡ÀÌÁî »ê¸ð·ÎºÎÅÍ ¼öÁ÷°¨¿° µûÀ§¿¡ ÀÇÇÏ¿© °¨¿°µÈ´Ù. °¨¿° ÈÄ Àϰú¼ºÀ¸·Î °¨±â¿Í °°Àº Áõ»óÀ» º¸À̸砹ÙÀÌ·¯½ºÇ÷ÁõÀ¸·Î µÇÁö¸¸ ¹ÙÀÌ·¯½º´Â °¨¼ÒµÇ°í 6~8ÁÖ ÈÄ¿¡´Â Ç×ü°¡ ¾ç¼ºÀ¸·Î µÈ´Ù. 6~10³â Á¤µµÀÇ ¹«ÁõÈļº º¸±Õ±â°£À» Áö³ª¼­ ¿¡ÀÌÁî°ü·ÃÁõÈıº(AIDS related syndrome)À¸·Î µÈ´Ù. ÀúÇ×·ÂÀÇ °¨¼Ò, ¸²ÇÁÀýºñ´ë, Ã¼Áß°¨¼Ò, ¹ß¿­, ¸¸¼º¼³»ç°¡ À̾îÁø´Ù. ±× ÈÄ ¿¡ÀÌÁî·Î µÇ¸ç, ÆóÆ÷ÀÚÃæÆó·Å µîÀÇ ¿øÃ溴, Ä­µð´Ù µîÀÇ Áø±ÕÁõ, Ç츣Æä½º¹ÙÀÌ·¯½º±º µîÀÇ ±âȸ°¨¿°ÀÌ À̾îÁø´Ù. ¶ÇÇÑ Ä«Æ÷½ÃÀ°Á¾, ¸²ÇÁÁ¾ µîÀ» º´¹ßÇØ¼­ »ç¸ÁÇÑ´Ù. ¹ÙÀÌ·¯½ºÀÇ ³úÁ¶Á÷³» Áõ½ÄÀ¸·Î Ä¡¸Å¸¦ ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. HIV-1Àº 10³â°£¿¡ »ç¸Á·üÀÌ 90%, HIV-2´Â 10%ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired perforating dermatosis
    ÈÄõõ°øÇǺκ´
  • perforating
    °üÅë-, õ°ø-
  • perforating artery
    °üÅ뵿¸Æ
  • perforating fiber
    °üÅë¼¶À¯
  • perforating folliculitis
    õ°øÅÐÁý¿°
  • perforating fracture
    °üÅë°ñÀý, ±¸¸Û°ñÀý
  • perforating pseudoxanthoma elasticum
    õ°øÅº·Â¼¶À¯°ÅÁþȲ»öÁ¾
  • perforating ulcer
    õ°ø¼º±Ë¾ç
  • perforating vein
    °üÅëÁ¤¸Æ
  • benign papular acantholytic dermatosis
    ¾ç¼º±¸Áø°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • bullous dermatosis
    ¹°ÁýÇǺκ´
  • dermatosis
    ÇǺκ´
  • lichenoid dermatosis
    ż±¸ð¾çÇǺκ´
  • occupational dermatosis
    Á÷¾÷ÇǺκ´
  • progressive pigmentary dermatosis
    ÁøÇà»ö¼ÒÇǺκ´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired immunodeficiency syndrome
    (¢¡AIDS) ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • dermatosis
    ÇǺκ´
  • perforating vein
    °üÅëÁ¤¸Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired perforating dermatosis
    ÈÄõõ°øÇǺκ´
  • reactive perforating collagenosis
    ¹ÝÀÀ°üÅë¾Æ±³ÁúÁõ
  • perforating artery
    °üÅ뵿¸Æ
  • perforating fiber
    °üÅë¼¶À¯
  • perforating folliculitis
    õ°øÅÐÁý¿°
  • perforating fracture
    (¢¡buttonhole fracture) °üÅë°ñÀý, ±¸¸Û°ñÀý
  • perforating
    °üÅë-
  • perforating pseudoxanthoma elasticum
    õ°øÅº·Â¼¶À¯°ÅÁþȲ»öÁ¾
  • perforating ulcer
    õ°ø±Ë¾ç
  • perforating vein
    °üÅëÁ¤¸Æ
  • benign papular acantholytic dermatosis
    ¾ç¼º±¸Áø°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • bullous dermatosis
    ¹°ÁýÇǺκ´
  • dermatosis
    ÇǺκ´
  • lichenoid dermatosis
    ż±¸ð¾çÇǺκ´
  • linear lichenoid dermatosis
    ¼±»óż±¸ð¾çÇǺκ´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired reactive perforating dermatosis
    ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired perforating dermatosis
    ÈÄõ¼º õ°ø¼º ÇǺκ´
  • reactive perforating collagenosis
    ¹ÝÀÀ¼º õ°ø ±³¿øÁõ
  • anterior perforating substantial branches
    ¾Õ°üÅëÁú°¡Áö
  • injury, perforating
    õ°ø»ó
  • Dermatosis
    ÇǺκ´
  • Gougerot-Blum pigmented purpuric lichenoid dermatosis
    ±¸Á¦·Î ºí·ë »ö¼Ò¼º Àڹݼº ż±¾ç ÇǺκ´
  • Grovers disease => transient acantholytic dermatosis
    Àϰú¼º ±Ø¼¼Æ÷ÇØ¸® ÇǺÎÁõ
  • acute febrile neutrophilic dermatosis ; Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ.
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • ashy dermatosis
    Àíºû ÇǺκ´
  • persistent acantholytic dermatosis
    Áö¼Ó¼º ±Ø¼¼Æ÷ÇØ¸® ÇǺκ´
  • pigmented reticulated dermatosis
    »ö¼Ò¸Á»óÇüÇǺÎÁõ(ßäáÈàõØÑßÒû¡ù«Ý±ñø)
  • progressive pigmentary dermatosis
    ÁøÇ༺ »ö¼Ò¼º ÇǺÎÁõ
  • progressive pigmentary dermatosis
    ÁøÇ༺ »ö¼Ò¼º ÇǺÎÁõ(òäú¼àõ ßäáÈàõ ù«Ý±ñø)
  • pustular dermatosis
    ³óÆ÷ÇǺκ´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired reactive perforating dermatosis
    ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired perforating dermatosis
    ÈÄõ¼º õ°ø¼º ÇǺκ´
  • reactive perforating collagenosis
    ¹ÝÀÀ¼º õ°ø ±³¿øÁõ
  • anterior perforating substantial branches
    ¾Õ°üÅëÁú°¡Áö
  • injury, perforating
    õ°ø»ó
  • perforating
    õ°ø¼º(ô¾Íîàõ)ÀÇ, °üÅë(λ÷×) ÀÇ.
  • perforating arteries
    °üÅ뵿¸Æ
  • perforating arterys ³ª arteriae perforantes
    °üÅ뵿¸Æ(¡­ÔÑØæ).
  • perforating branch
    °üÅë°¡Áö
  • perforating branches
    °üÅë°¡Áö
  • perforating calcific elastosis
    õ°ø¼º ¼®È¸ ź·Â¼¶À¯Áõ
  • perforating cutaneous nerve
    °üÅëÇǺνŰæ
  • perforating elastoma
    õ°ø¼º ź·Â¼¶À¯Á¾
  • perforating fiber
    °üÅë¼¶À¯(¡­àéë«).
  • perforating fiber
    °üÅë¼¶À¯
  • perforating fiber [sharpeys fiber]
    ½Ã¸àÆ®Áú°üÅë¼¶À¯
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Perforating branch
    °üÅë°¡Áö
    [¿¾ ¿ë¾î] °üÅëÁö
  • Perforating branches
    °üÅë°¡Áö
    [¿¾ ¿ë¾î] °üÅëÁö
  • Perforating arteries
    °üÅ뵿¸Æ
    [¿¾ ¿ë¾î] °üÅ뵿¸Æ
  • Perforating fiber
    °üÅë¼¶À¯
    [¿¾ ¿ë¾î] °üÅë¼¶À¯
  • Perforating veins
    °üÅëÁ¤¸Æ
    [¿¾ ¿ë¾î] °üÅëÁ¤¸Æ
  • Perforating cutaneous nerve
    °üÅëÇǺνŰæ
    [¿¾ ¿ë¾î] °üÅëÇǽŰæ
  • Perforating fiber [Sharpey`s fiber]
    ½Ã¸àÆ®Áú°üÅë¼¶À¯
    [¿¾ ¿ë¾î] ½Ã¸àÆ®Áú°üÅë¼¶À¯
  • Anterior perforating substantial branches
    ¾Õ°üÅëÁú°¡Áö
    [¿¾ ¿ë¾î] ÀüÀ¯°øÁúÁö
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • parasitic dermatosis
    ÇǺαâ»ýÃæÁõ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired antibody
    "ȹµæÇ×ü (üòÔðù÷ô÷), ÈÄõ¼ºÇ×ü (ý­ô¸àõù÷ô÷)"
  • acquired hemolytic anemia
    "ȹµæ¿ëÇ÷¼ººóÇ÷ (üòÔðéÁúìàõÞ¸úì), ÈÄõ¿ëÇ÷¼ººóÇ÷ (ý­ô¸éÁúìàõÞ¸úì)"
  • acquired immunity
    "ȹµæ¸é¿ª (üòÔðØóæ¹), ÈÄõ¸é¿ª (ý­ô¸Øóæ¹)"
  • acquired tolerance
    "ȹµæ³»¼º (üòÔðÒ±àõ), Èij»¼º (ý­Ò±àõ)"
  • C-reactive protein
    C¹ÝÀÀ(Úãëë) ´Ü¹éÁú(Ó±ÛÜòõ)
  • reactive enzyme centrifugetion
    ¹ÝÀÀÈ¿¼Ò ¿ø½ÉºÐ¸®(Úãëëý£áÈêÀãýÝÂ×î)
  • reactive hemolysis
    ¹ÝÀÀ¼º ¿ëÇ÷(ÚãëëàõéÁúì)
  • reactive lysis
    ¹ÝÀÀ¼º ¿ëÇØ(ÚãëëàõéÁú°)
  • reactive residue
    ¹ÝÀÀ¼º Àܱâ(ÚãëëàõíÑÐñ)
  • simian acquired immune deficiency syndrome
    ¿ø¼þÀÌ ÈÄõ¼º¸é¿ª°áÇÌÁúȯ(ý­ô¸àõØóæ¹ÌÀù¹òðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired
    ÈÄõ¼ºÀÇ, ȹµæ¼ºÀÇ
  • acquired heart disease
    ÈÄõ¼º½ÉÀåÁúȯ
  • perforating
    õ°ø¼ºÀÇ, °üÅëÀÇ
  • perforating artery
    °üÅ뵿¸Æ
  • perforating ulcer
    õ°ø¼º±Ë¾ç
  • C-reactive protein
    C-¹ÝÀÀ¼º´Ü¹éÁú
  • reactive bone excrescence
    ¹ÝÀÀ¼º°ñµ¹Ãâ
  • reactive fibrosis
    ¹ÝÀÀ¼º¼¶À¯È­
  • reactive hyperemia
    ¹ÝÀÀ¼ºÃæÇ÷
  • reactive interface
    ¹ÝÀÀ¼ºÁ¢Ã˸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RPC reactive perforating collagenosis; relapsing polychondritis; relative proliferative capacity
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
SARA sexually acquired reactive arthritis; Superfund Amendments and Reauthorization
SAIDS sexually acquired immunodeficiency syndrome; simian acquired immune deficiency syndrome
AFND acute febrile neutrophilic dermatosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SARA sexually acquired reactive arthritis
CBDC Chronic bullous dermatosis of childhood
LABD Linear IgA bullous dermatosis
SPD Subcorneal pustular dermatosis
TAD Transient acantholytic dermatosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acquired reactive perforating dermatosis
    ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acquired perforating dermatosis
    ÈÄõ¼º õ°ø¼º ÇǺκ´
  • perforating artery
    °üÅë µ¿¸Æ
    ´ë³»Àü±ÙÀÇ Á¤ÁöºÎ¸¦ ¶Õ°í ´ëÅðÀÇ ÈÄÃøºÎ¿¡ µµ´ÞÇÏ´Â ´ëÅð ½Éµ¿¸ÆÀÇ ºÐÁö¿¡¼­ ±â¿øÇÏ¿© ¿µ¾ç µ¿¸ÆÀ» ³»´Â µ¿¸Æ. ³»Àü±Ù, ½½±¼°î±Ù, µÐ±Ù ¹× ´ëÅð°ñ¿¡ ºÐÆ÷ÇÑ´Ù.
  • perforating hyperplasia
    õ°ø¼º Áõ½Ä
  • perforating vein
    °üÅëÁ¤¸Æ
    ´ëÅðÀÇ °üÅë µ¿¸ÆÀÇ ¹ÝÇà Á¤¸Æ. ½É´ëÅð Á¤¸ÆÀ¸·Î °³±¸ÇÑ´Ù.
  • C-reactive protein
    C-¹ÝÀÀ ´Ü¹é, C-¹ÝÀÀ¼º ´Ü¹éÁú
  • percent reactive antibody test
    ÆÛ¼¾Æ® ¹ÝÀÀ Ç×ü °Ë»ç
  • reactive bone excrescence
    ¹ÝÀÀ¼º °ñ µ¹Ãâ
  • reactive disease
    ¹ÝÀÀ¼º Áúȯ
  • reactive hyperemia
    ¹ÝÀÀ¼º ÃæÇ÷
    Ç÷·ù¸¦ ÀϽÃÀûÀ¸·Î Á¤Áö½ÃŲ Ç÷·ù Â÷´ÜÀ» ÇØÁ¦ÇÑ ÈÄ¿¡ ºÎºÐÀûÀ¸·Î Ç÷¾×ÀÌ °úÀ×À¸·Î µÇ´Â °Í.
  • reactive lesion
    ¹ÝÀÀ¼º º´¼Ò
  • reactive schizophrenia
    ¹ÝÀÀ¼º ºÐ¿­º´
    ¾ç¼ºÀÇ ¿¹Èİ¡ ±â´ëµÇ´Â, ÁַΠȯ°æ Á¶°Ç¿¡ ±âÀÎµÈ Á¤½Å ºÐ¿­.
  • acute febrile neutrophilic dermatosis
    ±Þ¼º ¹ß¿­¼º È£Áß±¸¼º ÇǺο°
  • angioneurotic dermatosis
    Ç÷°ü ½Å°æ¼º ÇǺκ´
  • benign papular acantholytic dermatosis
    ¾ç¼º ±¸Áø¼º ±Ø¼¼Æ÷ ÇØ¸® ÇǺκ´
  • chronic bullous dermatosis of childhood
    ¸¸¼º ¼Ò¾Æ ¼öÆ÷¼º ÇǺκ´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
reactive perforating collagenosis A rare skin disorder characterised by extrusion of collagen fibres through the epidermis; usually begins in infancy or childhood and appears clinically as recurrent umbilicated papules that resolve spontaneously. The condition may be inherited or acquired, the latter differing from Kyrle's disease because follicular involvement is absent.
(05 Mar 2000)
arthritis, reactive An abacterial form of arthritis developing after infection at a site distant from the affected joint or joints. The causative bacteria cannot be cultured from synovial specimens but bacterial antigens have been demonstrated in cells from the synovial fluid and membrane. It often follows yersinia infection.
(12 Dec 1998)
brief reactive psychosis <psychiatry> A brief display of psychotic behaviour that lasts for at least several hours, but not more than one week. Typically these reactions are brought on by periods of increased stress (for example death of a loved one).
Symptoms include delusions, hallucinations, disordered thinking, impaired speech and bizarre dress.
(27 Sep 1997)
reactive arthritis Reiter's syndrome is also called reactive arthritis since it is thought to involve the immune system which is reacting to the presence of bacterial infections in the genital, urinary, or gastrointestinal systems. Accordingly, certain people's immune systems are genetically primed to react aberrantly when these areas are exposed to certain bacteria. The aberrant reaction of the immune system leads to inflammation in the joints and eyes.
(12 Dec 1998)
reactive astrocyte <cell biology> A round to oval astrocyte cell with abundant cytoplasm containing glial filaments and an eccentric nucleus; may contain two nuclei in the cell hypertrophy of astrocytes.
Synonym: gemistocyte, gemistocytic cell, reactive astrocyte, reactive cell.
(05 Mar 2000)
reactive attachment disorder Markedly disturbed and developmentally inappropriate social relatedness that begins before age 5 and is associated with grossly pathological child care. The child may persistently fail to initiate and respond to social interactions in a developmentally appropriate way (inhibited type) or there may be a pattern of diffuse attachments with nondiscriminate sociability (disinhibited type).
(12 Dec 1998)
reactive cell <cell biology> A round to oval astrocyte cell with abundant cytoplasm containing glial filaments and an eccentric nucleus; may contain two nuclei in the cell hypertrophy of astrocytes.
Synonym: gemistocyte, gemistocytic cell, reactive astrocyte, reactive cell.
(05 Mar 2000)
reactive depression A psychological state occasioned directly by an intensely sad external situation (frequently loss of a loved person), relieved by the removal of the external situation (e.g., reunion with a loved person).
(05 Mar 2000)
reactive hyperaemia Hyperaemia following the arrest and subsequent restoration of the blood supply to a part.
(05 Mar 2000)
reactive inhibition Tendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses.
(12 Dec 1998)
reactive oxygen species Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development.
(12 Dec 1998)
reactive schizophrenia Those forms of severe schizophrenic disorders which are distinguished from process schizophrenia by their more acute onset, greater relation to environmental stress, and better prognosis.
(05 Mar 2000)
child reactive disorders Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.
(12 Dec 1998)
cold-reactive antibody See: cold agglutinin.
(05 Mar 2000)
C-reactive protein <protein> This blood test is used as an indicator of acute inflammation. C-reactive protein is a protein of the pentraxin family, produced by the liver during periods of inflammation and detectable in serum in various disease conditions particularly during the acute phase of immune response. Normally C-reactive protein should be negative in the bloodstream.
C-reactive protein is synthesised by hepatocytes and its production may be triggered by prostaglandin E1 or parogen. It consists of five polypeptide sub units forming a molecule of total molecular weight 105 kD. It binds to polysaccharides present in a wide range of bacterial, fungal and other cell walls or cell surfaces and to lecithin and to phosphoryl or choline containing molecules. It is related in structure to Serum Amyloid. And C polysaccharide.
Conditions which can cause a positive C-reactive protein include: rheumatoid arthritis, lupus, pneumococcal pneumonia, rheumatic fever, cancer, tuberculosis and myocardial infarction.
A positive C-reactive protein may also be seen in the later half of pregnancy and in some who are taking birth control pills.
See: acute phase proteins
(06 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dermatosis
    ÇǺκ´
  • reactive
    (Àڱؿ¡ ´ëÇØ)¹Î°¨ÇÑ;¹ÝÀÀÀÌ ºü¸¥;¹Ýµ¿(º¹°í)ÀûÀÎ;¹Ý¹ßÀûÀÎ;¹ÝÀÀÀûÀÎ;¹ÝÀÛ¿ëÀûÀÎ;~ly
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á